Qianhai Health Holdings Limited (0911.HK)
HKD 0.21
(0.0%)
HKD 0.21
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | - HKD | -100.0% |
| 2022 | 487 Thousand HKD | 0.0% |
| 2021 | - HKD | -100.0% |
| 2020 | 666 Thousand HKD | -22.47% |
| 2019 | 859 Thousand HKD | 1163.24% |
| 2018 | 68 Thousand HKD | -57.23% |
| 2017 | 159 Thousand HKD | -36.4% |
| 2016 | 250 Thousand HKD | -28.37% |
| 2015 | 349 Thousand HKD | -76.29% |
| 2014 | 1.47 Million HKD | -46.86% |
| 2013 | 2.77 Million HKD | 0.0% |
| 2012 | - HKD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - HKD | 0.0% |
| 2024 Q2 | - HKD | 0.0% |
| 2023 Q3 | - HKD | -100.0% |
| 2023 Q1 | 123 Thousand HKD | -74.74% |
| 2023 FY | - HKD | -100.0% |
| 2023 Q2 | 123 Thousand HKD | 0.0% |
| 2023 Q4 | - HKD | 0.0% |
| 2022 FY | 487 Thousand HKD | 0.0% |
| 2022 Q4 | 487 Thousand HKD | 0.0% |
| 2022 Q3 | 487 Thousand HKD | 0.0% |
| 2022 Q2 | - HKD | 0.0% |
| 2022 Q1 | - HKD | 0.0% |
| 2021 FY | - HKD | -100.0% |
| 2021 Q4 | - HKD | 0.0% |
| 2021 Q2 | 306 Thousand HKD | 0.0% |
| 2021 Q3 | - HKD | -100.0% |
| 2021 Q1 | 306 Thousand HKD | -54.05% |
| 2020 Q3 | 666 Thousand HKD | 68.61% |
| 2020 FY | 666 Thousand HKD | -22.47% |
| 2020 Q2 | 395 Thousand HKD | 0.0% |
| 2020 Q1 | 395 Thousand HKD | -54.02% |
| 2020 Q4 | 666 Thousand HKD | 0.0% |
| 2019 FY | 859 Thousand HKD | 1163.24% |
| 2019 Q4 | 859 Thousand HKD | 0.0% |
| 2019 Q3 | 859 Thousand HKD | -79.49% |
| 2019 Q1 | 4.18 Million HKD | 6060.29% |
| 2019 Q2 | 4.18 Million HKD | 0.0% |
| 2018 Q1 | 114 Thousand HKD | -28.3% |
| 2018 FY | 68 Thousand HKD | -57.23% |
| 2018 Q4 | 68 Thousand HKD | 0.0% |
| 2018 Q3 | 68 Thousand HKD | -40.35% |
| 2018 Q2 | 114 Thousand HKD | 0.0% |
| 2017 Q1 | 205 Thousand HKD | -18.0% |
| 2017 Q2 | 205 Thousand HKD | 0.0% |
| 2017 FY | 159 Thousand HKD | -36.4% |
| 2017 Q3 | 159 Thousand HKD | -22.44% |
| 2017 Q4 | 159 Thousand HKD | 0.0% |
| 2016 FY | 250 Thousand HKD | -28.37% |
| 2016 Q4 | 250 Thousand HKD | 0.0% |
| 2016 Q3 | 250 Thousand HKD | 0.0% |
| 2016 Q2 | - HKD | 0.0% |
| 2016 Q1 | - HKD | -100.0% |
| 2015 Q3 | 349 Thousand HKD | 0.0% |
| 2015 Q2 | - HKD | 0.0% |
| 2015 Q1 | - HKD | -100.0% |
| 2015 FY | 349 Thousand HKD | -76.29% |
| 2015 Q4 | 349 Thousand HKD | 0.0% |
| 2014 Q2 | 2.15 Million HKD | 0.0% |
| 2014 Q1 | 2.15 Million HKD | -22.09% |
| 2014 Q3 | 1.47 Million HKD | -31.79% |
| 2014 Q4 | 1.47 Million HKD | 0.0% |
| 2014 FY | 1.47 Million HKD | -46.86% |
| 2013 Q4 | 2.77 Million HKD | 0.0% |
| 2013 FY | 2.77 Million HKD | 0.0% |
| 2013 Q1 | - HKD | 0.0% |
| 2013 Q3 | 2.77 Million HKD | 0.0% |
| 2012 FY | - HKD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 2.07 Million HKD | 100.0% |
| Grand Pharmaceutical Group Limited | 990.02 Million HKD | 100.0% |
| Extrawell Pharmaceutical Holdings Limited | 117.12 Million HKD | 100.0% |
| Wai Yuen Tong Medicine Holdings Limited | 276.2 Million HKD | 100.0% |
| Lee's Pharmaceutical Holdings Limited | 70.63 Million HKD | 100.0% |
| Essex Bio-Technology Limited | 36.05 Million HKD | 100.0% |
| Tongfang Kontafarma Holdings Limited | 12.8 Million HKD | 100.0% |
| PuraPharm Corporation Limited | 81.09 Million HKD | 100.0% |
| SSY Group Limited | 1.94 Billion HKD | 100.0% |
| JBM (Healthcare) Limited | 43.8 Million HKD | 100.0% |
| Jacobson Pharma Corporation Limited | 592.2 Million HKD | 100.0% |
| China Resources Pharmaceutical Group Limited | 16.61 Billion HKD | 100.0% |